CD177 and cancer: While it is likely that RHAMM and other intracellular proteins are released to the extracellular milieu with the cellular death that accompanies cancer, inflammation, and wounding, multiple lines of evidence suggest that RHAMM is not a cell-surface receptor under physiological conditions.